Short Interest in ViaDerma, Inc. (OTCMKTS:VDRM) Increases By 1,287.5%

ViaDerma, Inc. (OTCMKTS:VDRM) saw a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 11,100 shares, a growth of 1,287.5% from the November 30th total of 800 shares. Based on an average trading volume of 3,981,600 shares, the short-interest ratio is presently 0.0 days.

ViaDerma Trading Down 5.1 %

Shares of VDRM opened at $0.01 on Friday. The stock has a fifty day moving average price of $0.01 and a two-hundred day moving average price of $0.01. ViaDerma has a 52-week low of $0.00 and a 52-week high of $0.02.

ViaDerma Company Profile

ViaDerma, Inc operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company’s lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.